HIV/Aids patients at risk as crucial drug expires
HIV/Aids patients at risk as crucial drug expires
- OVER 750 000 patients on HIV and Aids treatment have been affected by a stock-out of Tenolam drug at government health facilities, increasing patients' chances of developing health complications and adverse side effects after being introduced to new combinations, NewsDay has learnt.
- OVER 750 000 patients on HIV and Aids treatment have been affected by a stock-out of Tenolam drug at government health facilities, increasing patients' chances of developing health complications and adverse side effects after being introduced to new combinations, NewsDay has learnt.